Jason Drew Smith is CLO at UroGen Pharma Ltd. (URGN). They have made 14 open-market trades across 1 company since 2021, most recently 2026-09-08.
CIK 0001821479
1 open-market purchase totalling $39K since 2021, against 13 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| URGN | 53,141 | $1.8M |
Shares reported on the most recent Form 4, priced at the 2026-09-09 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| URGN | SELL | 2026-09-08 | 2026-09-09 | $42.54 | $65K | -1.5% | -15.9% | — |
| URGN | SELL | 2026-02-03 | 2026-02-11 | $19.69 | $147K | -2.1% | -13.0% | +40.5% |
| URGN | SELL | 2025-09-08 | 2025-09-09 | $19.11 | $29K | -13.4% | -20.8% | +11.3% |
| URGN | SELL | 2025-07-28 | 2025-07-30 | $19.14 | $288K | -4.9% | +1.5% | +5.3% |
| URGN | SELL | 2025-01-31 | 2025-02-04 | $11.14 | $82K | -4.6% | -9.7% | -3.0% |
| URGN | SELL | 2024-09-09 | 2024-09-12 | $13.08 | $20K | +0.3% | -5.8% | -12.1% |
| URGN | SELL | 2024-02-01 | 2024-02-05 | $15.78 | $131K | +18.2% | +13.5% | -12.9% |
| URGN | SELL | 2024-01-31 | 2024-02-02 | $15.74 | $131K | +17.9% | +13.0% | -12.5% |
| URGN | SELL | 2023-08-31 | 2023-09-05 | $18.01 | $68K | -11.1% | -24.3% | -25.5% |
| URGN | SELL | 2023-01-31 | 2023-02-02 | $10.12 | $17K | -12.6% | -5.5% | +19.5% |
| URGN | SELL | 2022-08-31 | 2022-09-02 | $7.21 | $26K | +24.8% | +9.5% | +15.8% |
| URGN | SELL | 2022-01-31 | 2022-02-02 | $7.58 | $3K | -2.4% | -14.9% | -4.9% |
| URGN | SELL | 2021-11-30 | 2021-12-02 | $12.03 | $46K | -17.0% | -18.6% | -49.2% |
| URGN | BUY | 2021-05-17 | 2021-05-18 | $15.71 | $39K | +0.9% | -3.9% | -14.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.